Johnson & Johnson Insider Trades

JNJ

Track insider trading activity from Johnson & Johnson (JNJ) executives and directors. Johnson & Johnson is a prominent American multinational pharmaceutical, biotechnology, and medical technologies corporation, headquartered in New Brunswick, New Jersey, and a component of the Dow Jones Industrial Average. The company's operations span pharmaceutical products, medical devices, and, historically, consumer products, though its consumer healthcare business was recently split off into Kenvue. Key figures in the company's leadership include Chairman and Chief Executive Officer Joaquin Duato. The Board of Directors and the executive committee comprise a number of individuals, including Mary C. Beckerle, Jennifer A. Doudna, Marillyn A. Hewson, and Joseph J. Wolk, among others. Over recent periods, Johnson & Johnson has generally seen insider trading activity predominantly in the form of sales by executives.

Trades Last 12 Months

All Insider Trades for Johnson & Johnson

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Wengel Kathryn E Evp, Chief TO And Risk Officer
Holding Value $7.88M 32,965 shares
Last Trade
Jun 11, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.38M 10,000 shares
$238.33
$239.08
Woods Eugene A. Director
Holding Value $1.53M 6,411 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38.2k 161 shares
$237.00
$239.08
Pinto Daniel E Director
Holding Value $555k 2,320 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.8k 134 shares
$237.00
$239.08
Holding Value $3.78M 15,791 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$50.7k 214 shares
$237.00
$239.08
Reed John C Evp, Innovative Medicine, R&d
Holding Value $8.59M 35,913 shares
Last Trade
May 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.74M 25,255 shares
$227.21
$239.08
Holding Value $5.09M 21,278 shares
Last Trade
Apr 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 975 shares
$230.65
$239.08
Holding Value $2.87M 12,010 shares
Last Trade
Apr 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 975 shares
$230.65
$239.08
Holding Value $3.7M 15,487 shares
Last Trade
Apr 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 975 shares
$230.65
$239.08
West Nadja Director
Holding Value $1.85M 7,730 shares
Last Trade
Apr 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 975 shares
$230.65
$239.08
Joly Hubert Director
Holding Value $2.2M 9,183 shares
Last Trade
Apr 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 975 shares
$230.65
$239.08
Beckerle Mary C Director
Holding Value $4.02M 16,797 shares
Last Trade
Apr 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 975 shares
$230.65
$239.08
Johnson Paula A Director
Holding Value $1.28M 5,359 shares
Last Trade
Apr 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 975 shares
$230.65
$239.08
Morikis John G Director
Holding Value $368k 1,540 shares
Last Trade
Apr 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$355k 1,540 shares
$230.65
$239.08
Holding Value $2.61M 10,899 shares
Last Trade
Apr 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 975 shares
$230.65
$239.08
Decker Robert J VP Corporate Controller
Holding Value $0 0 shares
Last Trade
Feb 27, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.01M 4,075 shares
$248.42
$239.08
Schmid Timothy Evp, WW Chair, Medtech
Holding Value $6.08M 25,447 shares
Last Trade
Feb 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$325k 1,322 shares
$245.66
$239.08
Broadhurst Vanessa Evp, Global Corp Affairs
Holding Value $5.5M 23,003 shares
Last Trade
Feb 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.51M 6,197 shares
$243.39
$239.08
Swanson James D. Evp, CIO
Holding Value $6.14M 25,698 shares
Last Trade
Feb 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.98M 20,521 shares
$242.70
$239.08
Wolk Joseph J Exec Vp, CFO
Holding Value $17.3M 72,347 shares
Last Trade
Feb 17, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.7M 64,693 shares
$243.36
$239.08
Taubert Jennifer L Evp, Wwc. Innovative Medicine
Holding Value $883k 3,692 shares
Last Trade
Feb 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$838k 3,441 shares
$243.43
$239.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up